Currently, single-use small-molecule drugs, such as clofoctol and ivacaftor, have been shown to inhibit the proliferation and progression of cancer stem cells by reducing the expression of CD44, CD133, and Sox2 genes [68-70], but whether PZD inhibits the proliferation of lung cancer by regulating cancer stemness needs further research. This evidence concerns the gene PROM1 and lung carcinoma.